Frazier Life Sciences VIII, L.P.

Insider Reports History

Location: Seattle, WA
Signature: Frazier Life Sciences VIII, L.P., By: FHM Life Sciences VIII, L.P., its general partner, By: FHM Life Sciences VIII, L.L.C., its general, partner, By: /s/ Steve R. Bailey, Chief Financial Officer
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Company	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	8,764,232	$31,032,393	$3.54	24 Oct 2023	Direct
ALPINE IMMUNE SCIENCES, INC.	10%+ Owner	Common Stock	1,484,115	$18,907,625	$12.74	11 Feb 2022	Direct
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	23,688	$83,874	$3.54	24 Oct 2023	By The Heron Living Trust 11/30/2004
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	19,381	$68,624	$3.54	24 Oct 2023	By Topper Family Revocable Trust
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	11,266	$39,891	$3.54	24 Oct 2023	By Topper Group II LLC
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	8,687	$30,759	$3.54	24 Oct 2023	By Patrick J. Heron
Arcutis Biotherapeutics, Inc.	10%+ Owner	Common Stock	7	$25	$3.54	24 Oct 2023	FHM Life Sciences VIII, L.L.C.

Symbol	Company	Period	Transactions	Value $	Form Type	Role	Filing Time
ARQT	Arcutis Biotherapeutics, Inc.	24 Oct 2023	1	+$200,000	4	10%+ Owner	26 Oct 2023, 16:09
ARQT	Arcutis Biotherapeutics, Inc.	05 Aug 2022	1	+$5,000,000	4	10%+ Owner	09 Aug 2022, 16:34
/report/000120919122009821-frazier-life-sciences-viii-l-p-2022-02-11	ALPINE IMMUNE SCIENCES, INC.	11 Feb 2022	1	+$799,989	4	10%+ Owner	15 Feb 2022, 16:00
/report/000120919121057010-frazier-life-sciences-viii-l-p-2021-09-17	ALPINE IMMUNE SCIENCES, INC.	17 Sep 2021	2	$0	4	10%+ Owner	21 Sep 2021, 13:54
ARQT	Arcutis Biotherapeutics, Inc.	10 May 2021	3	$0	4	10%+ Owner	12 May 2021, 17:37